Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)

NCT01098097 · clinicaltrials.gov ↗

COMPLETED

Status

963

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

BIOLOGICAL: Peginterferon alpha
DRUG: Ribavirin

Sponsor

Merck Sharp & Dohme LLC